Literature DB >> 9880843

[Experiences with different telescope nails in treatment of pediatric osteogenesis imperfecta].

A Karbowski1, M Schwitalle, A Eckardt.   

Abstract

OBJECTIVE: The present study aims to examine and compare results after intramedullary rodding of long bones with the original Bailey/Dubow-nail and two modifications. PATIENTS AND METHODS: During the period 1985 to 1995 21 patients with an average age of 6.3 years (2-11 yrs) underwent intramedullary rodding of 83 long bones. Therefore 38 original Bailey/Dubow-nails, 36 nails with distal screws and 9 nails with distal K-wires were used. The mean observation period amounted to 5.7 years after insertion. Operation success was judged by bone growth, rod elongation, complications, implantation period, revision- and refracture rate.
RESULTS: Bone growth was about 90.6% of the normal value accompanied by an elongation of 71.4%. Best results could be achieved by the use of conventional nails, whereas nails with distal screw or K-wires showed most disturbance. Complications had to be scored in 33.7% and mainly consisted of rod migration with cortical perforation (15.7%), metaphyseal position of the distal screw (9.6%) or no elongation (6.0%). Average implantation period was 4.6 years with a 66.3% revision rate. Refractures after inadequate trauma happened in 3 cases (3.6%) after insertion of the screw-type nail.
CONCLUSIONS: The use of elongation rods in children with osteogenesis imperfecta promises successful fracture prevention and a comparably long implantation period. However, the original Bailey/Dubow-nail showed best results although the modified nails had been expected to be superior.

Entities:  

Mesh:

Year:  1998        PMID: 9880843

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  1 in total

1.  [Diagnosis and therapy of osteogenesis imperfecta].

Authors:  A Meurer; T Lewens; D Schmitt; T Vetter; P Drees
Journal:  Orthopade       Date:  2008-01       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.